Search

You searched for "globe"

1234 results found

ABDO approved as a Registered Centre by the Chartered Management Institute

23 January 2025 | education, training, industry, optometry, Dispensing optician
The Chartered Management Institute (CMI) has approved the Association of British Dispensing Opticians (ABDO) to be a Registered Centre. ABDO previously operated as an e-centre with CMI and this change allows ABDO to consider any future management and leadership training...

RCOphth Back to Basics - Byte sized topics for all

22 October 2025
The Royal College of Ophthalmologists Back to Basics - Byte sized topics for all
Ophthalmologica journal cover image.

Type 3 macular neovascularisation (MNV) due to age-related macular degeneration

3 October 2024 | | EYE - Vitreo-Retinal
This paper systematically reviews and summarises the current knowledge on type 3 neovascularisation due to age-related macular degeneration which is defined as neovascularisation originating from the retinal deep capillary plexus that grows towards the outer retina often penetrating the level...

Haag-Streit UK moves to exciting new premises

19 June 2023 | Company Profiles, Research & Development
Haag Streit UK is pleased to announce that we have moved our UK headquarters from Harlow to Bishop’s Stortford.

Haag-Streit Academy launches new ‘Skills Hub’

22 August 2024 | Research & Development, Recruitment & Personnel
Haag-Streit UK recently launched ‘Skills Hub’, an exciting new branch of Haag-Streit Academy.

Ollie Finn is elected as the 25th known Clerk of the Worshipful Company of Spectacle Makers

19 December 2025
The Worshipful Company of Spectacle Makers is pleased to announce that Ollie Finn has succeeded Helen Perkins as Clerk, becoming the 25th known Clerk of the Company. Ollie previously worked for two years as Clerk to the Worshipful Company of...

Scottish budget 2026–27: Optometry Scotland welcomes continued investment in community eyecare

4 February 2026 | optometry
Optometry Scotland (OS) welcomes the Scottish Budget 2026–27, which confirms continued investment in community optometry and reinforces its established role in delivering accessible eyecare across Scotland. The Budget confirms community eyecare funding of £144.5 million for 2026–27, representing a cash...

Telemedicine strategies in ophthalmology: harnessing established and emerging technologies for lasting solutions

7 December 2020 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - Oculoplastic, EYE - General
The author considers recent progress and shares insights from leading practitioners in telemedicine applications and digital technology strategies. Amidst COVID-19 and combined mitigation and suppression measures, hospitals and clinics have responded rapidly to strengthen telemedicine strategies and virtual healthcare services...

Pigmented paravenous retinochoroidal atrophy

4 December 2024 | | EYE - Imaging, EYE - Vitreo-Retinal
Presentation A 46-year-old Caucasian female was referred to the eye clinic by her local optician following a routine sight test. She was noted to have pigmentary retinal changes in both eyes but was asymptomatic with no visual complaints. At presentation...

A comparison of light sources in retinal imaging

1 October 2021 | | EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Before starting to talk about the light sources present in retinal imaging, it is necessary to start from the base: the light. Light is an electromagnetic wave whose smallest part is the photon (or quantum of light). A high frequency...

RCOphth 2024 Report

28 May 2024 | | EyeConUK, RCOphth2024, Royal College of Ophthalmology, events, meetings, reports, previews, Eye News
A comprehensive tapestry of all our RCOphth Annual Congress content captured between 20–23 May 2024.

PACK-crosslinking for infectious keratitis

1 October 2015 | | EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...